A novel measure of drug benefit–risk assessment based on Scale Loss Score

Quantitative methods have been proposed to assess and compare the benefit-risk balance of treatments. Among them, multicriteria decision analysis (MCDA) is a popular decision tool as it permits to summarise the benefits and the risks of a drug in a single utility score, accounting for the preference...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint-Hilary, Gaelle, Robert, Veronique, Gasparini, Mauro, Jaki, Thomas, Mozgunov, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728751/
https://www.ncbi.nlm.nih.gov/pubmed/30025499
http://dx.doi.org/10.1177/0962280218786526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728751/
https://www.ncbi.nlm.nih.gov/pubmed/30025499
http://dx.doi.org/10.1177/0962280218786526

Ejemplares similares